AMPH Amphastar Pharmaceuticals Inc.

NASDAQ
$23.78

Amphastar Pharmaceuticals Inc. (AMPH) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with AMPH's own trailing one-year pace, with 15% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
4
10 transactions
Purchases
$0
0 shares
Sales
$1.4M
55,148 shares
Net activity
-$1.4M
purchases less sales

How much of that selling was preplanned? 15% planned / 85% discretionary

10b5-1 plan sales $210.1K 3 transactions · 9,180 shares
Discretionary sales $1.2M 7 transactions · 45,968 shares

Largest single sale: $441.8K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Zhou Rong SENIOR EVP, PRODUCTION CENTER Sell 3,187 $23.63 $75.3K 169,203 −1.8% of holding
PRINS RICHARD K Director Sell 7,973 $20.30 $161.9K 29,625 −21.2% of holding
PETERS WILLIAM J CFO, EVP & TREASURER Sell 10b5-1 8,180 $22.48 $183.9K 172,846 −4.5% of holding
Zhou Rong SENIOR EVP, PRODUCTION CENTER Sell 9,787 $26.20 $256.4K 138,043 −6.6% of holding
Petersen Floyd F. Director Sell 2,426 $25.92 $62.9K 71,368 −3.3% of holding
Petersen Floyd F. Director Sell 1,737 $25.69 $44.6K 73,794 −2.3% of holding
PRINS RICHARD K Director Sell 4,179 $27.10 $113.3K 35,183 −10.6% of holding
Petersen Floyd F. Director Sell 16,679 $26.49 $441.8K 75,531 −18.1% of holding
Petersen Floyd F. Director Sell 10b5-1 500 $25.27 $12.6K 75,531 −0.7% of holding
Petersen Floyd F. Director Sell 10b5-1 500 $27.20 $13.6K 76,031 −0.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.